Menstrual migraine: clinical and therapeutical aspects

References

• MacGregor EA. Menstrual migraine: a clinical review. J. Fam. Plann. Repord. Health Care33(1), 36–47 (2007).
   Google Scholar
• MacGregor EA. ‘Menstrual’ migraine: towards a definition. Cephalalgia16(1), 11–21 (1996).
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders: 2nd Edition. Cephalalgia24(Suppl. 1), 9–169 (2004).
   PubMed Web of Science ®Google Scholar
• Edelson RN. Menstrual migraine and other hormonal aspects of migraine. Headache25(7), 376–379 (1985).
   PubMed Web of Science ®Google Scholar
• Loder E, Marcus DA. Migraine in Women. Decker BC (Ed.). Hamilton, Ontario, USA 102–111 (2004).
   Google Scholar
• Somerville BW. Estrogen-withdrawal migraine: I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology25(3), 239–244 (1975).
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology67(12), 2154–2158 (2006).
   PubMed Web of Science ®Google Scholar
• Loder EW. Menstrual migraine: pathophysiology, diagnosis, and impact. Headache46(Suppl. 2), S49–S54 (2006).
   Google Scholar
• Nattero G, Allais G, De Lorenzo C et al. Menstrual migraine: new biochemical and psychological aspects. Headache28(2), 103–107 (1988).
   PubMed Web of Science ®Google Scholar
• Nattero G, Allais G, De Lorenzo C et al. Relevance of prostaglandins in true menstrual migraine. Headache29(4), 233–238 (1989).
   PubMed Web of Science ®Google Scholar
• Fioroni L, Martignoni A, Facchinetti F. Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia15(4), 297–300 (1995).
   PubMed Web of Science ®Google Scholar
• Fioroni L, D’Andrea G, Alecci M, Cananzi A, Facchinetti F. Platelet serotonin pathway in menstrual migraine. Cephalalgia16(6), 427–430 (1996).
   PubMed Web of Science ®Google Scholar
• Benedetto C, Allais G, Ciochetto D, De Lorenzo C. Pathophysiological aspects of menstrual migraine. Cephalalgia17(Suppl. 20), S32–S34 (1997).
   PubMed Web of Science ®Google Scholar
• Silberstein SD. The role of sex hormones in Headache. Neurology42(3 Suppl. 2), 37–42 (1992).
   PubMed Web of Science ®Google Scholar
• MacGregor A. Menstruation, sex hormones and migraine. Neurol. Clin.15(1), 125–141 (1997).
   PubMed Web of Science ®Google Scholar
• Granella F, Sances G, Messa G, de Marinis M, Manzoni GC. Treatment of menstrual migraine. Cephalalgia17(Suppl. 20), 35–38 (1997).
   PubMed Web of Science ®Google Scholar
• MacGregor A. Migraine associated with menstruation. Funct. Neurol.15(Suppl. 3), S143–S153 (2000).
   PubMed Web of Science ®Google Scholar
• Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia23(4), 302–308 (2003).
   PubMed Web of Science ®Google Scholar
• MacGregor A, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology63(2), 351–353 (2004).
   PubMed Web of Science ®Google Scholar
• Granella F, Sances G, Allais G et al. Characteristics of menstrual and non-menstrual attacks in women with menstrually related migraine referred to headache centers. Cephalalgia24(9), 707–716 (2004).
   PubMed Web of Science ®Google Scholar
• Dowson AJ, Kilminster SG, Salt R, Clark M, Bundy MJ. Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache45(4), 274–282 (2005).
   PubMed Web of Science ®Google Scholar
• Martin VT, Wernke S, Mandell K et al. Defining the relationship between ovarian hormones and migraine headache. Headache45(9), 1190–1201 (2005).
   PubMed Web of Science ®Google Scholar
• Visser WH, Jaspers NM, de Vriend RH, Ferrari MD. Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia16(4), 264–269 (1996).
   PubMed Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology55(10), 1517–1523 (2000).
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet358(9294), 1668–1675 (2001).
   PubMed Web of Science ®Google Scholar
• Salonen R, Saiers J. Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analysis. Cephalalgia19(1), 16–19 (1999).
   PubMed Web of Science ®Google Scholar
• Solbach MP, Waymer RS. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet. Gynecol.82(5), 769–772 (1993).
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group. Obstet. Gynecol.86(6), 911–916 (1995).
   PubMed Web of Science ®Google Scholar
• Gross MLP, Barrie M, Bates D, Dowson A, Elrington G. The efficacy of oral sumatriptan in menstrual migraine: a prospective study. Cephalalgia15(Suppl. 14), 227 (1995).
   Google Scholar
• Landy S, Savani N, Shackelford SJ, Loftus J, Jones M. Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int. J. Clin. Pract.58(10), 913–919 (2004).
   PubMed Web of Science ®Google Scholar
• Nett R, Landy, S, Shackelford S, Richardson MS, Ames M, Lener M. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet. Gynecol.102(4), 835–842 (2003).
   PubMed Web of Science ®Google Scholar
• Silberstein S. The efficacy of zolmitriptan is unaffected by relationship to menses. Cephalalgia21(4), 241–548 (2001).
   PubMed Web of Science ®Google Scholar
• Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study. Headache44(2), 120–130 (2004).
   PubMed Web of Science ®Google Scholar
• Tuchman M, Hee A, Emeribe U, Silberstein S. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs20(12), 1019–1026 (2006).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Massiou H, Le Jeunne C, Johnson-Pratt L, McCarroll KA, Lines CR. Rizatriptan in the treatment of menstrual migraine. Obstet. Gynecol.96(2), 237–242 (2000).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Massiou H, McCarroll KA, Lines CR. Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data. Headache42(9), 917–923 (2002).
   PubMed Web of Science ®Google Scholar
• Massiou H, Silberstein SD, McCarrol KA, Allen C, Lines CR. Efficacy of rizatriptan in menstrual migraine: freedom from pain and associated symptoms at 2-h and 24-h sustained pain free status. Cephalalgia20, 343–344 (2000) (Abstract).
   Google Scholar
• Massiou H, Jamin C, Hinzelin G, Bidaut-Mazel C. Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur. J. Neurol.12(10), 774–781 (2005).
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Keywood C. Frovatriptan is effective in menstrually associated migraine. Cephalalgia20, 345 (2000).
   Google Scholar
• Allais G, Bussone G, De Lorenzo C et al. Frovatriptan in the acute attack of oral contraceptive menstrual migraine (OCMM): a pilot study. Cephalalgia26, 1390 (2006) (Abstract).
   Google Scholar
• Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol. Sci.27(Suppl. 2), S193–S197 (2006).
   PubMed Web of Science ®Google Scholar
• Mannix LK, Files J. The use of triptans in the management of menstrual migraine. CNS Drugs19(11), 951–972 (2005).
   PubMed Web of Science ®Google Scholar
• Hettiarachi J, Pitei D. Oral eletriptan is effective in treating menstrually-associated migraine and women on oral contraceptives or hormone replacement therapy. Presented at: the 42nd Meeting of the American Headache Society. Montreal, Canada, 23–25 June 2000.
   Google Scholar
• Silberstein SD, Armellino JJ, Hoffman HD et al. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin. Ther.21(3), 475–491 (1999).
   PubMed Web of Science ®Google Scholar
• Allais G, De Lorenzo C, Zonca M, Benedetto C, Nattero G. The challenge of menstrual migraine therapy. In: Management of Menstrual Migraine. Genazzani AR, Volpe A, Facchinetti F (Eds). The Parthenon Publishing Group, Casterton Hall, Carnforth, UK 27–38 (1993).
   Google Scholar
• Silberstein SD, Merriam GR. Estrogens, progestins, and headache. Neurology41(6), 786–792 (1991).
   PubMed Web of Science ®Google Scholar
• Loder E. Menstrual migraine: timing is everything. Neurology63(2), 202–203 (2004).
   PubMed Web of Science ®Google Scholar
• Vardi J, Rabey JM, Streifler M. Prostaglandins and their synthesis inhibitors in migraine. In: Practical Applications of Prostaglandins and their Synthesis Inhibitors. Karin SMM (Ed.). University Park Press, Baltimore, MD, USA 139–148 (1979).
   Google Scholar
• Sances G, Martignoni E, Fioroni L et al. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache30(11), 705–709 (1990).
   PubMed Web of Science ®Google Scholar
• Szekely B, Merryman S, Croft H et al. Prophylactic effects of naproxen sodium on perimenstrual headache: a double-blind, placebo-controlled study. Cephalalgia9(Suppl. 10), 452–453 (1989) (Abstract).
   Google Scholar
• Al-Waili NS. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur. J. Med. Res.5(4), 176–182 (2000).
   PubMedGoogle Scholar
• Giacovazzo M, Gallo MF, Guidi V, Rico R, Scaricabarozzi I. Nimesulide in the treatment of menstrual migraine. Drugs46(Suppl. 1), S140–S141 (1993).
   Google Scholar
• Diamond S. Menstrual migraine and non-steroidal anti-inflammatory agents. Headache24(1), 52 (1984).
   PubMed Web of Science ®Google Scholar
• Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl Acad. Sci. USA96(13), 7563–7568 (1999).
   PubMed Web of Science ®Google Scholar
• Granella F, Allais G, Benedetto C. Cyclo-oxygenase-2 inhibitors as short term prophylaxis of menstrually related migraine. A pilot study. Cephalalgia23, 731 (2003).
   Web of Science ®Google Scholar
• von Seggern RL, Mannix LK, Adelman JU. Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trial. Headache44(2), 160–165 (2004).
   PubMed Web of Science ®Google Scholar
• Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology51(1), 307–309 (1998).
   PubMed Web of Science ®Google Scholar
• Newman LC, Mannix LK, Landy S et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache41(3), 248–256 (2001).
   PubMed Web of Science ®Google Scholar
• Moschiano F, Allais G, Grazzi L et al. Naratriptan in the cyclic prophylaxis of pure menstrual migraine. Neurol. Sci.26(Suppl. 2), S162–S166 (2005).
   PubMed Web of Science ®Google Scholar
• Savani N, Loftus J, Mansbach H, Scott A. A randomized, double-blind, placebo-controlled, parallel group evaluation of oral naratriptan 1 mg twice daily as prophylactic treatment for menstrually associated migraine. Cephalalgia22, 25 (2002) (Abstract).
   Google Scholar
• Karageorgiou CE, Hatzidaki G, Robotis G et al. The role of naratriptan as a prophylaxis to the menstrual migraine: a pilot comparative to naproxen study. Headache42, 451 (2002) (Abstract).
   Google Scholar
• Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology63(3), 261–269 (2004).
   PubMed Web of Science ®Google Scholar
• Tuchman M, Hee A, Emeribe U. Oral zolmitriptan 2.5 mg demonstrates high efficacy and good tolerability in the prophylactic treatment of menstrual migraine headaches. Headache45, 771 (2005) (Abstract).
   Google Scholar
• D’Alessandro R, Gamberini G, Lozito A, Sacquegna T. Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine. Cephalalgia3(Suppl. 1), S156–S158 (1983).
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Sances G, Volpe A et al. Hypothalamus–pituitary–ovarian axis in menstrual migraine: effect of dihydroergotamine retard prophylactic treatment. Cephalalgia3(Suppl. 1), S159–S162 (1983).
   PubMed Web of Science ®Google Scholar
• Gallagher RM. Menstrual migraine and intermittent ergonovine therapy. Headache29(6), 366–367 (1989).
   PubMed Web of Science ®Google Scholar
• Calhoun AH. Four hypotheses for understanding menstrual migraine. Female Patient29, 38–45 (2004).
   Google Scholar
• De Lignières B. La migraine cataméniale. Rev. Prat.40, 395–398 (1990).
   PubMedGoogle Scholar
• Dalton K. Progesterone suppositories and pessaries in the treatment of menstrual migraine. Headache12(4), 151–159 (1973).
   PubMed Web of Science ®Google Scholar
• Freeman E, Rickels K, Sondheimer SJ, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA246(3), 349–353 (1990).
   Google Scholar
• de Lignières B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous estradiol. Br. Med. J.293, 1540 (1986).
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol. Endocrinol.2(2), 113–120 (1988).
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine. A double-blind placebo-controlled crossover study. Neurology67(12), 2159–2163 (2006).
   PubMed Web of Science ®Google Scholar
• Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia20(3), 170–174 (2000).
   PubMed Web of Science ®Google Scholar
• Smits MG, van der Meer YG, Pfeil JP, Rijnierse JJ, Vos AJ. Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache34(2), 103–106 (1994).
   PubMed Web of Science ®Google Scholar
• Pfaffenrath V. Efficacy and safety of percutaneous estradiol versus placebo in menstrual migraine. Proceedings of the 6th International Headache Congress, Paris, France. Cephalalgia13(Suppl. 13), S244 (1993) (Abstract).
   Google Scholar
• Pradalier A, Vincent D, Beaulieu PH, Baudesson G, Lauanay JM. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In: New Advances in Headache Research: 4. Clifford-Rose F (Ed.). Smith-Gordon, London, UK 129–134 (1994).
   Google Scholar
• Calhoun AH. A novel specific prophylaxis for menstrual-associated migraine. South. Med. J.97(9), 819–822 (2004).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Merriam GR. Sex hormones and headache (menstrual migraine). Neurology53(4 Suppl. 1), S3–S13 (1999).
   Google Scholar
• Raskin NH. Headache (2nd Edition). Churchill Livingstone, NY, USA 153–154 (1988).
   Google Scholar
• Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed. Pharmacother.56(6), 283–288 (2002).
   PubMed Web of Science ®Google Scholar
• Ferrante F, Fusco E, Calabresi P, Cupini LM. Phyto-oestrogens in the prophylaxis of menstrual migraine. Clin. Neuropharmacol.27(3), 137–140 (2004).
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache31(5), 298–301 (1991).
   PubMed Web of Science ®Google Scholar
• Whitty CW, Hoackaday JM, Whitty MM. The effect of oral contraceptives on migraine. Lancet1, 856–859 (1966).
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Scow RD, Preece C, Riggs M, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet. Gynecol.95(2), 261–266 (2000).
   PubMed Web of Science ®Google Scholar
• Loder E, Buse DC, Golub JR. Headache as a side effect of combination estrogen–progestin oral contraceptives: a systematic review. Am. J. Obstet. Gynecol.193, 636–649 (2005).
   PubMed Web of Science ®Google Scholar
• Martin VT. Menstrual migraine: a review of prophylactic therapies. Curr. Pain. Headache Rep.8(3), 229–237 (2004).
   PubMedGoogle Scholar
• Allais G, Bussone G, De Lorenzo C, Mana O, Benedetto C. Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurol. Sci.26(Suppl. 2), S125–S129 (2005).
   Web of Science ®Google Scholar
• Cachrimanidou AC, Hellberg D, Nilsson S, Waldenstrom U, Olsson SE, Sikstrom B. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception48(3), 205–216 (1993).
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Cressman BE, Waldrop E, Holleman S, Kuehl TJ. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet. Gynecol.89(2), 179–183 (1997).
   PubMed Web of Science ®Google Scholar
• Anderson FD, Hait H. The Seasonale-301 Study Group. A multicenter, randomized, study of an extended cycle oral contraceptive. Contraception68(2), 89–96 (2003).
   PubMed Web of Science ®Google Scholar
• Sulak P, Willis S, Kuehl T, Coffee A, Clark J. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache47, 22–37 (2007).
   PubMed Web of Science ®Google Scholar
• Magos AL, Zilkha KJ, Studd JW. Treatment of menstrual migraine by oestradiol implants. J. Neurol. Neurosurg. Psychiatr.46(11), 1044–1046 (1983).
   PubMed Web of Science ®Google Scholar
• Lichten EM, Bennett RS, Whitty AJ, Daoud Y. Efficacy of danazol in the control of hormonal migraine. J. Reprod. Med.36(6), 419–424 (1991).
   PubMed Web of Science ®Google Scholar
• O’Dea JP, Davis EH. Tamoxifen in the treatment of menstrual migraine. Neurology40(9), 1470–1471 (1990).
   PubMed Web of Science ®Google Scholar
• Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and “add-back” therapy. Fertil. Steril.67(2), 390–393 (1997).
   PubMed Web of Science ®Google Scholar
• Martin V, Wernke S, Mandell K et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache43(3), 309–321 (2003).
   PubMed Web of Science ®Google Scholar
• Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. Br. Med. J.330(7482), 63 (2005).
   PubMed Web of Science ®Google Scholar
• Allais G, De Lorenzo C, Mana O, Benedetto C. Oral contraceptives in women with migraine: balancing risks and benefits. Neurol. Sci.25(Suppl. 3), S211–S214 (2004).
   PubMedGoogle Scholar